Ms. Kelly Anne Davis, MA, LAC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 |
Ms. Deborah Lee, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 746 Highway 34, Suite 3, Matawan, NJ 07747 Phone: 732-264-8878 Fax: 732-566-7727 |
Mrs. Pegeen Hansen, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4122 Route 516, Suite C, Matawan, NJ 07747 Phone: 732-679-4500 Fax: 732-679-4549 |
Mrs. Linda M Alba-lichardi, MSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 Fax: 732-566-0433 |
Marion Dowd, LCADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 Fax: 732-566-0433 |
Kathleen Breslin, LPC, ATR-BC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 Fax: 732-566-0433 |
Emily Boyle Counselor Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 |
Ms. Marybeth Magno, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 746 Highway 34, Ste 3, Matawan, NJ 07747 Phone: 732-264-8878 Fax: 732-566-7727 |
Raquel Figueroa Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 |
Elissa Scano Counselor Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 |
Jennifer O'keefe Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 |
Connor Dibella Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 |
News Archive
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
Part of the reason tuberculosis-causing bacteria are so good at colonizing the human body is that they have defenses against the body's immune system.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
› Verified 1 days ago